-+ 0.00%
-+ 0.00%
-+ 0.00%

Nautilus Biotechnology Q2 EPS $(0.11) Beats $(0.14) Estimate, Sales $190.000K

Benzinga·07/28/2026 10:12:22
Listen to the news
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported $190.000 thousand in sales this quarter.